Comment on Eevia receiving a grant of approx. SEK 2.7m and multiple orders totaling approx. SEK 2.0m - Analyst Group
Eevia Health Plc (”Eevia” or “the Company”) announced on Tuesday, March 19th, that the Company has received a grant of approx. SEK 2.7m (EUR 243k) from Business Finland for finalizing a development project for the documentation of bioactivity on Eevia’s products. Eevia executed the project in 2023 and submitted the final report in Q1-24, which has now been approved.
Länk till analysen i sin helhet: https://analystgroup.se/kommentarer/comment-on-eevia-receiving-a-grant-of-approx-sek-2-7m-and-multiple-orders-totaling-approx-sek-2-0m/